FRI-105 - Update on the Safety and Efficacy of REP 2139 Monotherapy and Subsequent Combination Therapy with Pegylated Interferon Alpha-2A in Caucasian Patients with Chronic HBV/HDV Co-Infection
| Autor: | Bazinet, M., Pantea, V., Cebotarescu, V., Cojuhari, L., Jimbei, P., Albrecht, J., Schmid, P., Krawczyk, A., Karimzadeh, H., Roggendorf, M., Vaillant, A. |
|---|---|
| Zdroj: | In Journal of Hepatology 2016 64(2) Supplement:S584-S585 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect